title: Cardio-oncology: an ongoing evolution.
abstract: Cancer survivorship has been greatly impacted with the development of modern cancer treatments. While significant strides have been made in managing many types of cancer, now physicians face new challenges. Over the past decades, cardiovascular events in cancer survivors have increased in prevalence, driving the development of multidisciplinary cardio-oncology programs. Additionally, as cancer patients live longer, their risk of developing secondary cardiovascular events increases. The rapid development of novel cancer therapies will continue to generate questions of cardiac risk and cardiac protection in cancer patients over time. We wish to outline the development of cardio-oncology in its present state, and provide future perspectives for the discipline.
authors.affiliation: School of Medicine, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, USA.
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: Petek
authors.affiliation: Division of Cardiology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195, USA.
authors.forename: Chris
authors.initials: C
authors.lastname: Greenman
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
authors.forename: Joerg
authors.initials: J
authors.lastname: Herrmann
authors.affiliation: Department of Cardiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Ewer
authors.affiliation: Sarcoma Unit, The Institute of Cancer Research & The Royal Marsden Hospital, Fulham Road, SW3 6JJ, London, UK.
authors.forename: Robin L
authors.initials: RL
authors.lastname: Jones
mesh_terms: D002309:Cardiology / Q000379:methods* / Q000639:trends; D066126:Cardiotoxicity / Q000517:prevention & control / Q000628:therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D004452:Echocardiography; D017408:Guidelines as Topic; D006801:Humans; D008495:Medical Oncology / Q000379:methods* / Q000639:trends; D009369:Neoplasms / Q000150:complications* / Q000628:therapy
keywords: anthracycline; cancer therapy; cardio-oncology; cardiotoxicity